Clinical Trial Update: A Pilot Study of Probiotic Saccharomyces Boulardii Use in Chronic Heart Failure Patients. Estudo PROICA [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial studying the probiotic Saccharomyces boulardii in chronic heart failure patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Saccharomyces boulardii (Saccharomyces boulardii)

Snippet

Sponsor: Universidade Federal Fluminense | Conditions: Heart Failure | Phase 2 | Status: COMPLETED